Kyverna Therapeutics, Inc.
NASDAQKyverna Therapeutics enters its May 27 earnings date with short sellers making their most aggressive move of the year — and the stock, paradoxically, gaining 11% on the week. Short interest has jumped 22% in a single week to 11.9% of the free float. That is not routine drift. Over the prior five weeks, SI had held in a tight 4.2–4.3 million share band. Then, between Thursday May 8…
Snapshot as of 14 May 2026
Kyverna Therapeutics enters its May 27 earnings date with short sellers making their most aggressive move of the year — and the stock, paradoxically, gaining 11% on the week. Short interest has jumped 22% in a single…
Short sellers are piling into KYTX ahead of May earnings. The lending market tells a conflicting story — and that contradiction is worth watching. Short interest in Kyverna Therapeutics hit 11.9% of free float as of…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for KYTX — free to start on ORTEX.
Sign up for free →Open KYTX on ORTEX